Nanoformulations of natural products for management of metabolic syndrome

Yasamin Davatgaran Taghipour,1–3 Marziyeh Hajialyani,4 Rozita Naseri,5 Mahvash Hesari,6 Pantea Mohammadi,6 Azzurra Stefanucci,7 Adriano Mollica,7 Mohammad Hosein Farzaei,4,6 Mohammad Abdollahi81Department of Medical Nanotechnology, School of Advanced Medical Sciences, Tabriz Unive...

Full description

Bibliographic Details
Main Authors: Taghipour YD, Hajialyani M, Naseri R, Hesari M, Mohammadi P, Stefanucci A, Mollica A, Farzaei MH, Abdollahi M
Format: Article
Language:English
Published: Dove Medical Press 2019-07-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/nanoformulations-of-natural-products-for-management-of-metabolic-syndr-peer-reviewed-article-IJN
_version_ 1831591207978926080
author Taghipour YD
Hajialyani M
Naseri R
Hesari M
Mohammadi P
Stefanucci A
Mollica A
Farzaei MH
Abdollahi M
author_facet Taghipour YD
Hajialyani M
Naseri R
Hesari M
Mohammadi P
Stefanucci A
Mollica A
Farzaei MH
Abdollahi M
author_sort Taghipour YD
collection DOAJ
description Yasamin Davatgaran Taghipour,1–3 Marziyeh Hajialyani,4 Rozita Naseri,5 Mahvash Hesari,6 Pantea Mohammadi,6 Azzurra Stefanucci,7 Adriano Mollica,7 Mohammad Hosein Farzaei,4,6 Mohammad Abdollahi81Department of Medical Nanotechnology, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran; 2Phytopharmacology Interest Group (PPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran; 3Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; 4Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran; 5Internal Medicine Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran; 6Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran; 7Department of Pharmacy, G. d’Annunzio University of Chieti-pescara, Chieti 66100, Italy; 8Toxicology and Diseases Group, the Institute of Pharmaceutical Sciences (TIPS) and Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, IranAbstract: Metabolic syndrome is a common metabolic disorder which has become a public health challenge worldwide. There has been growing interest in medications including natural products as complementary or alternative choices for common chemical therapeutics regarding their limited side effects and ease of access. Nanosizing these compounds may help to increase their solubility, bioavailability, and promisingly enhance their efficacy. This study, for the first time, provides a comprehensive overview of the application of natural-products-based nanoformulations in the management of metabolic syndrome. Different phytochemicals including curcumin, berberine, Capsicum oleoresin, naringenin, emodin, gymnemic acid, resveratrol, quercetin, scutellarin, stevioside, silybin, baicalin, and others have been nanosized hitherto, and their nanosizing method and effect in treatment and alleviating metabolic syndrome have been reviewed and discussed in this study. It has been discovered that there are several pathways or molecular targets relevant to metabolic disorders which are affected by these compounds. Various natural-based nanoformulations have shown promising effect in treatment of metabolic syndrome, and therefore can be considered as future candidates instead of or in conjunction with pharmaceutical drugs if they pass clinical trials successfully.Keywords: nanoformulation, natural products, metabolic syndrome, diabetes
first_indexed 2024-12-18T01:19:59Z
format Article
id doaj.art-308c5fc0c1ff478289d9cce5ccf40e25
institution Directory Open Access Journal
issn 1178-2013
language English
last_indexed 2024-12-18T01:19:59Z
publishDate 2019-07-01
publisher Dove Medical Press
record_format Article
series International Journal of Nanomedicine
spelling doaj.art-308c5fc0c1ff478289d9cce5ccf40e252022-12-21T21:25:51ZengDove Medical PressInternational Journal of Nanomedicine1178-20132019-07-01Volume 145303532147165Nanoformulations of natural products for management of metabolic syndromeTaghipour YDHajialyani MNaseri RHesari MMohammadi PStefanucci AMollica AFarzaei MHAbdollahi MYasamin Davatgaran Taghipour,1–3 Marziyeh Hajialyani,4 Rozita Naseri,5 Mahvash Hesari,6 Pantea Mohammadi,6 Azzurra Stefanucci,7 Adriano Mollica,7 Mohammad Hosein Farzaei,4,6 Mohammad Abdollahi81Department of Medical Nanotechnology, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran; 2Phytopharmacology Interest Group (PPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran; 3Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran; 4Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran; 5Internal Medicine Department, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran; 6Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran; 7Department of Pharmacy, G. d’Annunzio University of Chieti-pescara, Chieti 66100, Italy; 8Toxicology and Diseases Group, the Institute of Pharmaceutical Sciences (TIPS) and Faculty of Pharmacy, Tehran University of Medical Sciences (TUMS), Tehran, IranAbstract: Metabolic syndrome is a common metabolic disorder which has become a public health challenge worldwide. There has been growing interest in medications including natural products as complementary or alternative choices for common chemical therapeutics regarding their limited side effects and ease of access. Nanosizing these compounds may help to increase their solubility, bioavailability, and promisingly enhance their efficacy. This study, for the first time, provides a comprehensive overview of the application of natural-products-based nanoformulations in the management of metabolic syndrome. Different phytochemicals including curcumin, berberine, Capsicum oleoresin, naringenin, emodin, gymnemic acid, resveratrol, quercetin, scutellarin, stevioside, silybin, baicalin, and others have been nanosized hitherto, and their nanosizing method and effect in treatment and alleviating metabolic syndrome have been reviewed and discussed in this study. It has been discovered that there are several pathways or molecular targets relevant to metabolic disorders which are affected by these compounds. Various natural-based nanoformulations have shown promising effect in treatment of metabolic syndrome, and therefore can be considered as future candidates instead of or in conjunction with pharmaceutical drugs if they pass clinical trials successfully.Keywords: nanoformulation, natural products, metabolic syndrome, diabeteshttps://www.dovepress.com/nanoformulations-of-natural-products-for-management-of-metabolic-syndr-peer-reviewed-article-IJNnanoformulationsnatural productsmetabolic syndromediabetes
spellingShingle Taghipour YD
Hajialyani M
Naseri R
Hesari M
Mohammadi P
Stefanucci A
Mollica A
Farzaei MH
Abdollahi M
Nanoformulations of natural products for management of metabolic syndrome
International Journal of Nanomedicine
nanoformulations
natural products
metabolic syndrome
diabetes
title Nanoformulations of natural products for management of metabolic syndrome
title_full Nanoformulations of natural products for management of metabolic syndrome
title_fullStr Nanoformulations of natural products for management of metabolic syndrome
title_full_unstemmed Nanoformulations of natural products for management of metabolic syndrome
title_short Nanoformulations of natural products for management of metabolic syndrome
title_sort nanoformulations of natural products for management of metabolic syndrome
topic nanoformulations
natural products
metabolic syndrome
diabetes
url https://www.dovepress.com/nanoformulations-of-natural-products-for-management-of-metabolic-syndr-peer-reviewed-article-IJN
work_keys_str_mv AT taghipouryd nanoformulationsofnaturalproductsformanagementofmetabolicsyndrome
AT hajialyanim nanoformulationsofnaturalproductsformanagementofmetabolicsyndrome
AT naserir nanoformulationsofnaturalproductsformanagementofmetabolicsyndrome
AT hesarim nanoformulationsofnaturalproductsformanagementofmetabolicsyndrome
AT mohammadip nanoformulationsofnaturalproductsformanagementofmetabolicsyndrome
AT stefanuccia nanoformulationsofnaturalproductsformanagementofmetabolicsyndrome
AT mollicaa nanoformulationsofnaturalproductsformanagementofmetabolicsyndrome
AT farzaeimh nanoformulationsofnaturalproductsformanagementofmetabolicsyndrome
AT abdollahim nanoformulationsofnaturalproductsformanagementofmetabolicsyndrome